<乌鸦传媒>Overall Survival Data in for Gilteritinib as AML Salvage Tx FLT3 Inhibitor tops chemotherapy in randomized trial Apr 01, 2019
<乌鸦传媒>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<乌鸦传媒>CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<乌鸦传媒>Aggressive Tx Remains Common for Adults, Children Near Death Many patients continue with treatments they probably don't need Mar 30, 2019
<乌鸦传媒>Transplant No Help in Hypodiploid ALL Similar 5-year outcomes with or without HSCT, regardless of MRD status Mar 29, 2019
<乌鸦传媒>Are Patients Better Off With Image-Guided Bone Marrow Biopsy? Prospect of sedation has some going to interventional radiology Mar 29, 2019
<乌鸦传媒>Digital Rectal Exams: Worth the Trouble? Howard Wolinsky looks for the evidence, and doesn't find much Mar 29, 2019
<乌鸦传媒>Potential Game Changer for Endometrial Cancer A 30% response rate in recurrent/advanced disease, 49% in MSI-H tumors Mar 20, 2019
<乌鸦传媒>Early Data Send Strong Signal in Advanced Gyn Cancers Clinical benefit rate tops 90% in pair of single-center studies Mar 19, 2019
<乌鸦传媒>'End of the Road' for Trabectedin in Ovarian Cancer? Trial stopped for futility, but 13-month OS improvement seen in patients with BRCA mutations Mar 19, 2019
<乌鸦传媒>When PARP Inhibitors Fail in Ovarian Cancer Study identifies subgroup for whom another go could be worthwhile Mar 18, 2019
<乌鸦传媒>Avelumab Combo Falls Short in Advanced Ovarian Ca But showed promise in PD-L1-positive group Mar 18, 2019
<乌鸦传媒>Ticagrelor Antidote Clears Phase I Trial Quick reversal of P2Y12 inhibitor possible in healthy participants Mar 17, 2019
<乌鸦传媒>PARP Inhibitor Benefit Gets a TWiST in Recurrent Ovarian Ca Analysis attempts to quantify patients' quality of survival Mar 17, 2019
<乌鸦传媒>No Rise in Cancer Risk for RA Patients on Actemra Similar to malignancy risk with TNF inhibitors and abatacept Mar 14, 2019
<乌鸦传媒>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OS Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<乌鸦传媒>Cancer Drug for Precancerous Lesions? Fluorouracil cream bested other common actinic keratosis treatments Mar 08, 2019
<乌鸦传媒>Vaccine Prolongs Remission in Triple-Negative Breast Cancer Effect in hard-to-treat subgroup "clinically meaningful" Mar 07, 2019
<乌鸦传媒>Monkees' Peter Tork Dies of Rare Salivary Gland Cancer But what is adenoid cystic carcinoma? Mar 07, 2019
<乌鸦传媒>Do Keloids Convey a Higher Cancer Risk? Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
<乌鸦传媒>Lymphadenectomy Often Useless in Ovarian Cancer No survival benefit with normal nodes after complete macroscopic resection Mar 01, 2019
<乌鸦传媒>Black History Month: Talking With Jennifer Webb, MD How mentorship helped her overcome barriers Feb 28, 2019
<乌鸦传媒>Liquid Biopsy Matches Tissue for NSCLC Guidance Increased mutation detection rate, faster turnaround time Feb 27, 2019
<乌鸦传媒>Zytiga May Up Mortality Risk in Prostate Cancer Patients With CVD Increased hospitalizations seen among all abiraterone-treated patients Feb 27, 2019
<乌鸦传媒>One-Time FIT Adequately Detects CRC but Not Advanced Adenomas Accuracy depends on varying test thresholds for positive result Feb 25, 2019
<乌鸦传媒>Significant Decline in Precancerous Cervical Lesions in U.S. Proportion of lesions with HPV16/18 fall across age, ethnic groups Feb 21, 2019
<乌鸦传媒>No Survival Bump Yet with Tivozanib for RCC Selected studies on kidney cancer from the Genitourinary Cancers Symposium Feb 18, 2019
<乌鸦传媒>'Encouraging' Early Data with Keytruda in High-Risk Bladder Ca Will responses in non-muscle-invasive, BCG-unresponsive disease prove durable? Feb 17, 2019
<乌鸦传媒>Bladder Ca Treatment Enters 'Post-Checkpoint' Era Early trials show responses with antibody-drug conjugates Feb 16, 2019
<乌鸦传媒>Doubling Down on Antiandrogens Improves PFS in Metastatic Prostate Ca But lack of OS data for enzalutamide-ADT may hold it back Feb 15, 2019 video
<乌鸦传媒>Immunotherapy Lurches Forward in Prostate Cancer Combination trials in mCRPC yield responses in immunologically "cold" tumor Feb 15, 2019
<乌鸦传媒>Surveillance of Low-Risk Prostate Cancer Tripled Radical prostatectomy gained some ground for high-risk disease Feb 12, 2019 video
<乌鸦传媒>Radiological Agent Shows Promise in Heavily Treated mCRPC PSA decline of 50% or greater in two-thirds of patients Feb 12, 2019 video
<乌鸦传媒>Better Survival for African-Americans With mCRPC Significant improvement vs whites with androgen-directed agents Feb 11, 2019 video
<乌鸦传媒>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxaban Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<乌鸦传媒>Fewer Colectomy Procedures Performed Among Ulcerative Colitis Patients Surveillance efforts may lead to more treatment options for this patient group Feb 08, 2019
<乌鸦传媒>Colonoscopy Misses More Adenomas Than Thought Forget 'one and done' -- adenomas per positive colonoscopy better measure of quality, researchers say Feb 08, 2019
<乌鸦传媒>Rats, My PSA Went Up. Do I Need Another Bleeping Biopsy? "Active surveillance" doesn't have to mean invasive testing for every biomarker blip Jan 29, 2019
<乌鸦传媒>Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<乌鸦传媒>Genetic Profiling Disappoints for CUP Survival But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
